Proteomics: A Promising Approach for Cancer Research
Proteome Signaling Dysregulation in Cancer, Therapeutic Interventions, and Future Perspectives, Volume 2
- Publisher's listprice EUR 157.99
-
65 526 Ft (62 406 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 6 553 Ft off)
- Discounted price 58 974 Ft (56 165 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
65 526 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 1 January 2026
- ISBN 9780443239083
- Binding Paperback
- No. of pages316 pages
- Size 229x152 mm
- Language English 700
Categories
Long description:
Proteomics: A Promising Approach for Cancer Research Volume 2 Proteome signaling dysregulation in cancer, therapeutic interventions, and future perspectives provides an updated overview of scientific knowledge, achievements, and findings in the field of cancer proteomics. The field of cancer proteomics is very dynamic, with emerging trends specifically related to clinical solutions. The book content was developed to help readers get up to speed on the topic and easily apply learnings into research or clinical practice.
Volume 2 covers proteome signaling, their dysregulation to therapeutics options and future prospects in 17 different signaling pathways. It capitalizes the enormous interest in proteomics among academics and gives new viewpoints on this topic in cancer treatment. It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment.
Table of Contents:
1. Breast cancer: JAK/STAT signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
2. Colorectal cancer: Notch signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
3. Lung cancer: Akt/PKB signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
4. Leukemia: Hedgehog signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
5. Gastric cancer: AMPK signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
6. Pancreatic cancer: Wnt signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
7. Cervical cancer: TGF? signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
8. Ovarian cancer: VEGF signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
9. Brain cancer: Hippo signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
10. Endometrial cancer: cAMP-dependent signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
11. Lymphoma: TLR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
12. Thyroid cancer: MAPK/Erk signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
13. Kidney cancer: mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
14. Liver cancer: Insulin signal transduction pathway dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
15. Bladder cancer: PI3K/Akt/mTOR signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
16. Skin cancer: Eph/ephrin signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
17. Esophageal Cancer: Nodal signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
